![Mark Theeuwes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Theeuwes
Amministratore Delegato presso Receptor Life Sciences, Inc.
Profilo
Mark Theeuwes is currently the President, Chief Executive Officer & Director at Receptor Life Sciences, Inc. and also serves as the Director at Epilepsy Foundation.
Previously, he worked as the Chief Operating Officer & Executive Vice President at Engage Therapeutics, Inc. from 2019 to 2020.
Posizioni attive di Mark Theeuwes
Società | Posizione | Inizio |
---|---|---|
Receptor Life Sciences, Inc.
![]() Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Receptor Life Sciences, Inc. operates as a pharmaceutical development company. It offer treatment of pain, central nervous systems, metabolic disorders, and gastrointestinal disorders. The company was founded in 2015 and is headquartered in Seattle, WA. | Amministratore Delegato | 19/01/2021 |
Epilepsy Foundation
![]() Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Direttore/Membro del Consiglio | 31/08/2022 |
Precedenti posizioni note di Mark Theeuwes
Società | Posizione | Fine |
---|---|---|
Engage Therapeutics, Inc.
![]() Engage Therapeutics, Inc. BiotechnologyHealth Technology Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ. | Direttore operativo | 01/06/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Engage Therapeutics, Inc.
![]() Engage Therapeutics, Inc. BiotechnologyHealth Technology Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ. | Health Technology |
Receptor Life Sciences, Inc.
![]() Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Receptor Life Sciences, Inc. operates as a pharmaceutical development company. It offer treatment of pain, central nervous systems, metabolic disorders, and gastrointestinal disorders. The company was founded in 2015 and is headquartered in Seattle, WA. | Health Technology |
Epilepsy Foundation
![]() Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Commercial Services |
- Borsa valori
- Insiders
- Mark Theeuwes